Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02915744 |
|---|---|
| Brief Title: | A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine (ATTAIN) |
| First Submitted : | September 22, 2016 |
| First Submitted that Met QC Criteria : | September 23, 2016 |
| First Posted : | September 27, 2016 (Estimate) |
| Results First Submitted : | July 6, 2021 |
| Results First Submitted that Met QC Criteria : | August 3, 2021 |
| Results First Posted : | August 27, 2021 |
| Last Update Submitted that Met QC Criteria : | April 10, 2023 |
| Last Update Posted : | April 14, 2023 |